Next Article in Journal
Synthesis and Biological Evaluation of N-Alkoxyphenyl-3-hydroxynaphthalene-2-carboxanilides
Next Article in Special Issue
The Role of Lectin-Carbohydrate Interactions in the Regulation of ER-Associated Protein Degradation
Previous Article in Journal
Theoretical Verification of Photoelectrochemical Water Oxidation Using Nanocrystalline TiO2 Electrodes
Previous Article in Special Issue
Protein-Carbohydrate Interaction between Sperm and the Egg-Coating Envelope and Its Regulation by Dicalcin, a Xenopus laevis Zona Pellucida Protein-Associated Protein
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 20
Issue 6
10.3390/molecules20069745
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Molecular Interactions of β-(1→3)-Glucans with Their Receptors

by
Laurent Legentil
1,2,
Franck Paris
1,2,
Caroline Ballet
1,2,
Sophie Trouvelot
3,
Xavier Daire
3,
Vaclav Vetvicka
4,* and
Vincent Ferrières
1,2,*
1
Ecole Nationale Supérieure de Chimie de Rennes, CNRS, UMR 6226, 11 Allée de Beaulieu, CS 50837, 35708 Rennes Cedex 7, France
2
Université européenne de Bretagne, F-35000 Rennes, France
3
INRA, UMR AgroSup/INRA/uB 1347 Agroécologie, Pôle Interactions Plantes-Microorganismes-ERL CNRS 6300, 21065 Dijon Cedex, France
4
Department of Pathology, University of Louisville, Louisville, KY 40202, USA
*
Authors to whom correspondence should be addressed.
Molecules 2015, 20(6), 9745-9766; https://doi.org/10.3390/molecules20069745
Submission received: 14 April 2015 / Accepted: 20 May 2015 / Published: 27 May 2015
(This article belongs to the Special Issue Protein-Carbohydrate Interactions, and Beyond)
Browse Figures
Versions Notes

Abstract

:
β-(1→3)-Glucans can be found as structural polysaccharides in cereals, in algae or as exo-polysaccharides secreted on the surfaces of mushrooms or fungi. Research has now established that β-(1→3)-glucans can trigger different immune responses and act as efficient immunostimulating agents. They constitute prevalent sources of carbons for microorganisms after subsequent recognition by digesting enzymes. Nevertheless, mechanisms associated with both roles are not yet clearly understood. This review focuses on the variety of elucidated molecular interactions that involve these natural or synthetic polysaccharides and their receptors, i.e., Dectin-1, CR3, glycolipids, langerin and carbohydrate-binding modules.

Graphical Abstract

1. Introduction

β-(1→3)-Glucans are homopolymers of glucose where each unit is linked to the next by a β-(1→3) bond. They are known to interact with various receptors in humans, invertebrates or microorganisms. Such recognition triggered various responses like immune cascade or digestion. Strangely, most receptors that specifically recognize β-(1→3)-glucans share common characteristics and some show great homology. The mechanisms involved in immunological and inflammatory responses induced by β-glucans or the degradation of β-glucans are complex. They may depend on several factors: characteristics of the β-(1→3)-glucan (molecular weight, degree of branching, solubility, 3D-conformation) and how glucans interact with their receptors. Amongst the latter, the main receptors are Dectin-1, complement receptor 3 (CR3), glycolipids or Carbohydrate Binding Module (CBM) associated with glucanases. Many reviews very interestingly describe a macroscopic view of the resulting biological effects [1,2]. Since information was widely accumulated during the past decade for humans or invertebrates [3], we propose herein an overview of the molecular interactions between these natural polysaccharides or synthetic analogs and their receptors, or mutants thereof.

2. Conformation of β-(1→3)-Glucans

The structural conformations of β-(1→3)-glucans in solution cannot be known precisely. This is mainly due to free and independent rotation of glycosidic bonds between residues and the interconversion of these residues between chair, half chair and boat cyclic conformations. As a result, these polysaccharides can be seen as random coils in solution. Computer assisted model building was used to predict the conformations of highest probability that possess a minimum of conformational energy, and where the coils are stabilized by intermolecular interactions. β-(1→3)-glucans were shown to exhibit preferentially a right or left-handed triple helix configuration in water. This was confirmed by experimental studies such as X-ray fiber diffraction [4], solid state 13C-NMR spectroscopy [5], multi-angle laser light scattering [6], fluorescence resonance energy transfer spectroscopy [7] and molecular dynamic simulation [8]. In the triple helical structure of β-(1→3)-glucans, the C-2 hydroxyl group of each glucose unit plays an important role in stabilizing the structure by interstrand hydrogen bonding. On the other hand, the primary hydroxyl is oriented toward the outside of the helical structure without any intrastructural interaction. This is why chemical modifications of β-(1→3)-glucans preferentially occur on the branched glucosyl residues or the 6 position: OH-2 and OH-4 connected to the main-chain are required to stabilize the inherent helical structure [9]. Interestingly, it has been established that the chemical modification of the C-6 position scarcely reduces the helix-forming character of β-(1→3)-glucan polysaccharides [10]. To provide an order of magnitude, X-ray diffraction patterns of curdlan [strictly linear β-(1→3)-glucan] in the anhydrous form revealed that it adopts a right-handed 61 triple helix with a diameter of 2.3 nm and a pitch of 1.84 nm. This corresponds to six glucose residues in one helix turn—every 1.84 nm [9].
When dissolved in an alkaline medium (pH higher than 13), in DMSO or at temperature higher than 135 °C, those cooperative interactions are lost. The polysaccharidic chains then adopt less organized conformations and form random coils. The chains can be reconstructed by mixing the solution with excess water [10]. The random coil can therefore be converted into a single helix by neutralization with HCl. Finally, the single helical conformation can be renatured to the original triple helix by heating or dialysis [11]. When renatured, some β-(1→3)-glucans, such as scleroglucan, are able to adopt unusual conformations, for instance circular triple helices structures [12]. The possible mechanism is that closed triple helices are converted into single strand by partially opening one end of the triple helix with sodium hydroxide. Subsequent neutralization returns it to the original closed triple helix. The partially opened structure can be maintained for up to 20 days [7,13]. The significant differences between the triple- and single-helix or partially opened conformations include the accessibility to OH-2 functions of the main-chain strand for further chemical modification [14].
The degree of polymerization (DP) of β-(1→3)-glucans is a determinant factor in their solubility in water. Unbranched laminarins with DPs lower than 20 are freely soluble in water [15]. However, linear β-(1→3)-glucosides derived from curdlan with DPs above 36 are insoluble in water because the cooperative interactions between chains becomes stronger than those between chains and water molecules [16]. However, when these polysaccharides bear (1→6)-linked glucosyl chains, like scleroglucan and schyzophyllan (DP above 100), their water solubility increases. This solubility depends on the frequency of side branches [17]. Removing those residues causes the polysaccharide to precipitate [18]. Finally, high molecular weight (DP > 1000) β-(1→3), (1→6)-glucans from yeast and fungal cell walls are insoluble in water. Solubility of β-(1→3)-glucans is better in alkaline media than in neutral water. This is due to the ionization of hydroxyl groups, disrupting the ordered structures. Organic solvents with the ability to form hydrogen bonds with the polysaccharidic chains such as DMSO and DMF are also good solvents for β-(1→3)-glucans.
It is essential to note that in biological systems, the gel state is the most typical state for β-(1→3)-glucans, ranging from compacted polysaccharides with low hydration, such as callose deposit, to expanded gels like the cell wall matrices of higher plants.

3. Interactions of β-(1→3)-Glucans with Human Main Receptors

3.1. Dectin-1

Dectin-1 [19] is a type II transmembrane protein present in leukocytes, with the highest levels of cell surface expression in neutrophils, macrophages, and dendritic cells. The human protein consists of 247 amino acids and three major domains [20]. By interacting with a particulate glucan, an immunoreceptor tyrosine-based activating motif (ITAM) is phosphorylated [21]. This transmembrane signaling triggers several biological effects, including the production of superoxide, increase of phagocytosis, and induction of cytokines or anti-fungal effectors [22]. Recently, it was also established that intraocular administration of particulate β-(1→3)-glucans induced axonal regeneration through interaction with Dectin-1 presenting retina-resident immune cells [23]. Interestingly, β-(1→3)-glucans should interact with two surface Dectin-1 receptors to induce intracellular Syk activation, and then formation of phagosomes for cellular internalization and mature phagolysosomes [24]. A Dectin-1/Syk/NF-kB signaling axis was further confirmed by experiments using glucan isolated from the fruit bodies of Grifola frondosa. The homogeneous β-glucans induce the activation of Syk and NF-kB signaling in macrophages resulting in significant anti-cancer activities [25].
Moreover, the strength of the biological response induced by Dectin-1/glucan interaction could also be dependent on the expression level of TLR2, and on cooperative ability of Dectin-1 and TLR2 to interact with β-(1→3)-glucans [21,26]. Following the internalization of the polysaccharide into the macrophage, Chan and coworkers hypothesized that shorter fragments of β-(1,3)-glucans, but still polymeric, are then released to be further taken up by granulocytes thanks to binding by complement receptor-3 (CR3; See corresponding chapter) [27].
Glucan/Dectin-1 interaction is made possible thanks to the presence of a key C-type lectin (CTL) on Dectin-1 as shown by Ohno and coworkers in 2004 [14]. Generally, ligation of CTL with galactosidic or mannosidic ligands requires at least a highly conserved sequence of three consecutive amino-acids within the carbohydrate recognition domain (CRD) of C-type lectins: glutamine-proline-aspartate (QPD) or glutamate-proline-asparagine (EPN), respectively [22]. This interaction is generally calcium-dependent since Ca2+ cations are likely to form a complex with both the peptidic sequence and the galactosyl or mannosyl residues [28]. Nevertheless, β-(1→3)-glucans are also recognized by Dectin-1 through a Ca2+-independent mode, suggesting modification of the C-type lectin action and so a different peptidic requirement. As nicely shown by Ohno, the glucan binding to the studied receptor involves two amino-acid residues, i.e., a tryptophan (W) and a histidine (H), separated by a third residue. Mutations of one or both residues significantly affected the ability of various glucans to bind Dectin-1.
Parallel to this study, binding mode with glycoconjugates was carried out on collectins, effector molecules of the immune system, which also contain a CTL domain [29]. It was assumed that interactions involving a tripeptide and Ca2+ cations are key determinants but that a further pocket was required for larger ligands. Indeed, considering the interactions of Dectin-1 and β-(1→3)-glucans based on a microarray technology, Feizi and coworkers have shown that a minimum of 10 or 11 glucosyl residues were required [30]. This polymer chain length was compatible with a possible defined conformation, so that high order local arrangement was hypothesized. An answer was initially attempted by Ohno who used a simple helix pre-arranged glucan. On a molecular scale, it was concluded that the protein preferred interacting with OH-4 and OH-6, rather than with OH-2. This assumption was later corroborated by STD-NMR technique. Such a NMR sequence is able to give a dynamic view of the contacts between a small molecule and its macromolecular receptor in solution. On this basis, it was established that Dectin-1 induced less contacts with H-2 and H-4 than with H-3, H-5, H-6 and anomeric H-1 [31]. This means that interactions occurred between the hydrophobic face of the glucan and hydrophobic groove of the lectin site through amino acid residues such as histidine and more particularly tryptophan. Nevertheless, it was also shown that both extremities may strongly interact with Dectin-1. Using similar NMR techniques, Yamaguchi and coworkers confirmed that the affinity of oilgo-glucans for Dectin-1 increased with the DP, the stronger binding being measured with laminarin as ligand [32].
Multivalent oligoglucans were recently obtained thanks to controlled grafting of synthetic glucans to proteins like Keyhole limpet hemocyanin (KLH) [33] or detoxified diphtheria toxin (CRM197) [34]. While the laminarihexaose do not bind effectively to Dectin-1, the corresponding multivalent conjugates exhibit strong affinity. In addition, a strong immune response in mice was measured. These results pave the way to the development of β-glucan based vaccine to protect itself against invasive microorganisms like Candida albicans or Aspergillus fumigatus.
It is well known that the primary structure of β-(1→3)-glucans is significantly dependent on its origin (seaweeds, fungi, yeasts) and isolation protocols. Differences were observed in terms of molecular weight, chain length, and branching. The latter parameter has a strong influence on the conformational behavior of the natural polysaccharides [8]. It was recently demonstrated that the existence of such side-chain (1→6)-branching, and its position, on short oligo-β-(1→3)-glucans may influence binding affinities with Dectin-1, IC50 values varying from 2.6 mM to 2.2 pM [35]. Moreover, interaction mechanisms of discontinuous cereal β-(1→3), β-(1→4)-glucans were partly elucidated. It was observed that these polysaccharides have weaker affinities than continuous β-(1→3)-glucans but that helical arrangement was not necessary to ensure interactions with Dectin-1 and that conformational adaptation was possible [36]. In conclusion, no general rules could be clearly drawn to explain elicitation of immunological responses since recognition of Dectin-1, with or without the assistance of TLRs, is strongly linked to the type of β-glucans used [37].

3.2. Langerin

Amongst dendritic cells, Langerhans cells are able to present surface langerin that bears a C-type lectin domain. It is, therefore, involved in viruses, fungi and bacteria binding, followed by internalization of the parasites, and induction of immunological responses [38]. Langerin is composed of two main parts: a carbohydrate-recognition domain and a region that can form trimers. Although its ability to complex with mannose-, fucose-, and N-acetyl-glucosamine-containing polysaccharide was well known, recent studies established molecular interactions with β-(1→3)-glucans. Geijtenbeek and coworkers showed that langerin is an important receptor for this family of polysaccharides which are commonly found at the surface of opportunistic and pathogenic microorganisms such as Candida and Saccharomyces species [39]. To complete this study, langerin was co-crystallized with laminaritriose [40]. Crystallographic data highlighted that the non-reducing glucose residue could coordinate calcium cation through hydrogen bonds involving its OH-3 and OH-4 functions, the cation being coordinated within a tweezer consisting of two asparagine and two glutamine residues. The authors also demonstrated the ability of the reducing glucose residue to bind calcium through the free β-anomeric hydroxyl and its vicinal OH-2. They also concluded that such interactions on both reducing and non-reducing extremities induced conformation with minimum energy. Very recently, the transport of glucan particles was studied in the context of gut-associated lymphoid tissue. Once again, CTLs were determined to be suitable receptor, and more particularly that of langerin presented by leukocytes within the intestinal mucosa [41].

3.3. CR3

Complement Receptor 3 (CR3) is a receptor belonging to the β2-integrin family, found on immune cells such as leukocytes, macrophages and NK cells. As part of the complement system (innate immunity), CR3 is the main receptor involved in clearing iC3b-opsonized fungal pathogens from an organism by stimulating phagocytosis and degranulation. This heterodimeric transmembrane glycoprotein is made up of a common β2 subunit (CD18), noncovalently bound to the αM subunit (CD11b) [42]. This α-chain is unique in containing a lectin-like site, involved in priming of CR3 and its proper adhesion conformation [43,44].
β-Glucans can bind with high affinity to the lectin site and the overlapping I-domain of CD11b. However, a double recognition has been shown to be mandatory to trigger the immune system and leading to a cytotoxic activity. This relies on a simultaneous binding of iC3b-opsonized molecules and β-glucan on CR3 [45]. This dual ligation was first highlighted with the use of yeasts that show the polysaccharide within their membrane. Once administered, the fungi pathogen is opsonized by iC3b, and binds the two active sites of CR3, leading to the desired cytotoxic effect [46]. More precisely, β-glucans activate CR3 for binding with iC3b-coated cells, which can be antibody-coated cancer cells, fungi or yeast [27,47]. These findings were confirmed by inhibition by anti-CD11b antibodies and by use of CR3 KO mice [48].
In order to enhance the immune response in humans, unable to synthetize β-(1→3)-glucans, many groups have worked over the past years on the oral [49] or intravenous administration of soluble polysaccharides, synthetic or natural, willing the same cytotoxic effects [50]. Bose’s team showed that soluble β-glucans of 10 kDa could bind human neutrophils and monocytes in a concentration-dependent and receptor-specific manner [51]. It was also proposed, and confirmed later with STD-NMR studies [31], that small soluble oligosaccharides (less than 10 repeating units) cannot bind the lectin site [30]. More recently, Crich and coworkers analyzed the effects of shorter hydroxylamine analogues of β-glucan. Interestingly, they obtained a CR3 activation, hence a phagocytosis activity, suggesting that the number of repeating glucosyl entities is not the only factor modulating the priming of CR3 [52]. The high biological efficiency of these small analogues compared to the activity of longer polysaccharides was assumed to be based on increased hydrophobicity of the α-face of the synthetic 2-deoxy hydroxylamine mimetics. As a matter of fact, it was demonstrated that laminaripentaose, a five-membered oligoglucan, had an immunostimulatory effect in vivo in murine models [53]. Other short β-(1→3)-glucan mimetics also triggered immunostimulating potential at least equivalent to that of laminarine, i.e., deoxy-derivatives [54,55,56] or thioglucan analogues [57], the latter being active on cancer stem cells.

3.4. Glycolipids, Scavenger Receptors and other Receptors

Lactosylceramide (LacCer, CDw17) is a glycosphingolipid highly expressed on the plasma membranes of human neutrophils and epithelial cells. In 1998, thanks to biochemical interaction studies between PGG-glucan and human leukocytes, Zimmerman and coworkers identified LacCer as a β-(1→3)-glucan receptor [58]. It has been demonstrated thereafter that β-(1→3)-glucan-bounded LacCer triggers various responses in human neutrophil, such as chemotaxis [59], oxidative burst and NF-κB activity [60], and cytokine secretion [61]. All together, these effects lead to the increase of neutrophil antimicrobial activity. However, the mechanisms behind this immune cascade remain unclear [62].
Other lipid-conjugates are also able to interact with β-(1→3)-glucans. Acetylated low density lipoproteins (AcLDLs) presented by human U937 cells however prefer negatively polyglucans [63], for instance phosphorylated ones, or linear glucosyl chains [64]. It was shown that branched schizophyllan had no ligation affinity for LDL. More recently, Lozano and coworkers have highlighted that binding of β-(1→3)-glucan zymosan with the CD5 ectodomain, a receptor present on the surface of mature T and B1a cells and belonging to the scavenger receptor cysteine-rich family, induced MAP kinase activation and cytokine release [65].
Finally, it was recently established that molecular components of inflammasome are able to interact with fungal glucans [66]. The inflammasome is a proteic oligomeric complex involved in the regulation of the innate immunity. It is notably composed of caspases 1 and 5, PYCARD, and proteins of the nucleotide-binding oligomerization domain-like receptors (NLR). Along the latters, the cryopirin, also called NALP3, should be not essential for the production of interleukin-1β but the formation of a complex built of candida β-glucan/Dectin-1/TLR2 proceeded in production of the interleukin. In this context, results obtained by Matikainen and coworkers underlined that b-glucans interacting with cytoplasmic NLRP3 inflammasome triggered IL-1β production in human macrophages [67].

3.5. Other Lectins

In addition to major β-(1→3)-glucan receptors Dectin-1 and CR3, other proteins were described as β-(1→3)-glucan recognition protein (βGRP). L-Ficolin is a lectin that participates in the innate immunity cascade via the complement activation [68]. It is activated by contact with capsulated bacteria through recognition of a large panel of PAMP (Pathogens Associated Molecular Pattern) including lipoteichoic acid [69], acetylcholine, GlcNAc-containing cell wall [70] and β-(1→3)-glucan [71]. The group of Gaboriaud and coworkers identified a β-(1→3)-glucan binding domain located on two contiguous sub-sites of the trimeric form of the protein [72]. The polymer binds through four glucosyl units between two sides of a cleft formed by sub-sites S3 and S4. The recognition sites adopt a curved conformation that accommodates well with the linear β-(1→3)-glucan. First anchorage of the reducing end occurs at S4 site and is stabilized thanks to hydrophobic interaction between the reducing sugar and a tryptophan. Additional H-bonds are involved, one in particular mediated by a calcium cation. Toward the non-reducing end, direct and water-mediated hydrogen bonds occurred mostly with 2-OH of the glucosyl residue. This pattern is the first described example of contiguous sub-site that recognizes one specific assembly.

4. Elicitation of Immune Responses in Invertebrates

4.1. Insects Receptors

Insects do not possess acquired immunity. They solely rely on innate immune cascade upon invasion of parasite. Such pathways include prophenoloxidase (proPO) cascade, Toll and immune deficiency pathways [73,74]. They could be triggered when βGBP bind to β-(1→3)-glucan expressed at the surface of invasive parasites [75,76]. Various βGRP have been identified among different species of insect [77,78,79]. They share a common organization with two distinct domains [80]. The C-terminal domain is a glucanase-like domain that presents some homology with identified xylanase or starch-hydrolyzing enzyme. It could neither hydrolyze β-(1→3)-glucan nor bind to insoluble glucan [81,82]. In some examples however, some affinity with soluble laminarin was detected [83]. Its absence reduces the immune response drastically but its complete role is still to be determined. The N-terminal domain was described as the β-(1→3)-glucan recognition domain. It is made of 100 amino-acids on average and is highly conserved among insect species. Different research groups managed to produce the N-terminal domain of βGRP (N-βGBP) from different species as recombinant protein [84,85,86,87,88]. Subsequent NMR and X-ray crystallography analyses highlighted a common structure for all the deciphered N-βGBP. They all have an immunoglobulin like β-sandwich fold composed of two antiparallel β-sheets.
The first model described was the N-terminal domain of Drosophila Gram-negative binding protein 3 (GNBP3) [88]. GNBP3 is a circulating protein found in the hemolymph of Drosophila that senses fungal invasion and subsequently triggers a proteolitic cascade that eventually activates the Toll receptors [89]. Activation of the Toll pathway leads to the production of antimicrobial peptides.
N-terminal domain of GNBP3 exhibits strong affinity for linear non-soluble β-(1→3)-glucan curdlan but low binding to oligoglucans with a degree of polymerization (DP) less than 16. Lectin and CBM generally bind weakly to carbohydrates due to low energy-binding bonds involved in the interaction [90,91]. In order to counterpart these non-favorable interactions, two strategies prevailed. In the first case, the receptors agglomerate around the macromolecules thus increasing the affinity by clustering effect. In the second case, the binding surface on the receptors is wide enough to accommodate a large portion of the polysaccharides. Here, Roussel and coworkers [88] identified a large aromatic rich binding platform made of the triad Tyr75-Trp77-Tyr79, which could interact with glucan thanks to hydrophobic interactions. This platform could be accessible to the polysaccharide only if the negatively charged loop, that hides two of the three aromatic amino-acids, is put back. The authors hypothesized that a linear β-(1→3)-glucan with high DP was necessary to open this lid. Once the polysaccharide is in the groove, the loop could close and thus form an additional stabilizing hydrophobic bond with the glucan.
Later, Kanagawa and coworkers [86] described the X-ray crystallographic data of the N-βGRP of both Plodia interpunctella and Bombyx mori in complex with laminarihexaose (Figure 1). Such N-βGRP is able to activate the proPO cascade leading to the encapsulation of the invading micro-organism [83,92]. In the reported data, these authors confirmed the localization of the interaction site on the convex β-sheet of the globular protein like for Drosophila and the stabilization of the resulting complex thanks to a long loop between the β3 and β4 strand. These results are in contradiction with previous data on N-βGRP of B. mori that localize the site of recognition on the concave C-terminal face of the protein by NMR titration in the presence of laminarin [87]. Such discrepancies might be associated with the use of different sources of laminarin. Interestingly, they also highlighted the crucial role of Trp76 that interacts with two molecules of laminarihexaose in analogy with Trp77 in Drosophila [86]. However, the protein appears to have a preformed and rigid site of interaction thus ruling out any adaptation of the receptors at the substrate approach. Three molecules of laminarihexaose interact with each other in the groove to form a β-(1→3)-glucan like macromolecules. β-(1→3)-glucan like curdlan adopts in water a right-handled helical conformation thanks to inter-chain hydrogen bonds between the 2-O groups and intra-strand H-bond between 4-O and 5-O atoms [4]. As such, curdlan or laminaran present a hydrophobic core and a rather hydrophilic surface. There is therefore no need of an aromatic patch that can stack with the carbohydrate residue in the recognition site. Interestingly, X-ray data exhibited two major contributions in the affinity site. First, hydrophobic bonds (and not stacking) are found between 6 glucoses belonging to three strands of laminarohexaose and hydrophobic residue Leu, Trp and Phe. Secondly, polar and charged residues like Hist, Asp and Arg circle the hydrophobic domain and contribute to a stabilizing H-bond network with 4-OH and 6-OH pending at the surface of the “triple helical”-like laminarihexaoses.
Figure 1. Solvent accessible surface of Plodia interpunctella N-βGRP complexed with laminarihexaose (data from Protein Data Bank entry 3AQZ).
Figure 1. Solvent accessible surface of Plodia interpunctella N-βGRP complexed with laminarihexaose (data from Protein Data Bank entry 3AQZ).
The idea of a large site of interaction that can accommodate a large portion of the β-(1→3)-glucan to compensate low-energy binding was recently reinvestigated using ITC and analytical ultracentrifugation techniques [85]. The authors compared the behavior of N-βGRP from P. interpunctella in presence of laminarihexaose or laminarin. First, numerous 1H-1H NOE distance constraints were detected on the non-bound and bound protein, thus validating the conformational rigidity of the protein highlighted previously. The analysis of sedimentation velocity shows the formation of a macro-complex N-βGRP/laminarin where one laminarin bind two proteins. In addition to agglutination of the protein on laminarine, the complex is stabilized thanks to a salt bond between two adjacent proteins. Such complex stability is influenced by the amount of β-(1→6)-branching on the glucan. The authors also hypothesized that the agglutination of βGRP around the molecule of laminarin is a crucial step to trigger the serine protease cascade. Such cluster effect was recently identified as the mechanism involved when soluble laminarin interacted with the N-terminal domain of βGRP2 from Manduca sexta [84]. At equimolar concentration of the glucan and the protein, an irreversible insoluble aggregate forms that is able to activate the serine protease cascade. Oligomerization of N-βGRP2 around a molecule of laminarin was possible thanks to the packing of proteins in a side-by-side fashion via electrostatic interactions similar to the one found for B. mori and P. interpunctella [85]. This clustering forces the laminarin in solution into a partial triple-helix configuration similar to curdlan and, as such, insoluble in water.
When a larger concentration of the polysaccharide is used, no such precipitate appears, even if a clustering occurs. Dispersion of the protein along the chain of laminarin allows enough flexibility to the polymer to be soluble. Interestingly, this complex shows less activity upon immune cascade activation than the insoluble precipitate. These data give a partial explanation on the observed fact that the immune cascade activation reaches a maximum at a certain concentration of laminarin and then decreases with increasing amounts of sugar [93,94].

4.2. Crustacean Receptors

As insects, crustaceans rely on their innate immune system to fight invasive parasites [95,96]. Various pattern recognition proteins are involved in the recognition of epitopes at the surface of the microorganism. They include β-glucan binding or recognition protein (βGBP or βGRP), lipopolysaccharide and β-(1→3)-glucan binding protein (LGBP), Gram-negative binding or recognition protein (GNBP or GNRP) and peptidoglycan binding or recognition protein (PGBP or PGRP) [97,98,99].
The first example of βGBP has been identified in the blood of the shrimp Pacifastacus leniusculus [100]. Upon β-(1→3)-glucan binding, it mediates different defense reactions like opsonisation or ProPo cascade. Sequencing shows unique repeating sequences not found in mammalian lectins and a sequence that shows similarity with identified glucanase. Later on, numerous βGBP were purified and cloned in various crustaceans like crayfish [101], shrimp [95] or crab [102]. No systematic analysis of the recognition pattern has yet been published. However, an attempt to understand their specificity for β-(1→3)-glucan using in silico docking and molecular dynamics simulation were reported recently. For example, the recognition domain of β-GBP from Episesarma tetragnonum was computed by homology with the catalytic domain of a laminarase from Thermotoga maritima [103]. The author identified a polar groove at the central core of the protein where only laminarin can fit. Same homology modeling was performed on LGBP isolated from the shrimp Fenneropenaeus indicus [104]. Such protein shows no specificity for glucan as it also binds to LPS. It is typically described as a multi-domain protein with sub-sites dedicated to the recognition of specific PAMP and to the cell-adhesion process. This sub-site comprises a binding groove rich in polar and charged amino-acids that seems to fit best with oligo-glucan models.
A last family of β-(1→3)-glucan binding domain were identified as part of the coagulation Factor G of the horseshoe crab [105]. Upon binding with long glucan (DP greater than 7), Factor G dimerized and the resulting activated specie activates the hemolymph clotting cascade. Factor G is a heterodimeric serine protease zymogen comprising two sub-units α and β that are linked through non-covalent bonds [106]. The α-unit presents similar domains as glucanase and it was reported that only the C-terminal domain of the unit binds effectively to the glucan [107]. This domain carries two independent glucan-binding sites and certainly interacts with the long chain of β-(1→3)-glucan by multiple interactions. An action mechanism was predicted based on these findings. First detection of fungal β-(1→3)-glucans occurs on both independent sites of the C-terminal domain of the α-unit leading to a stable complex. The non-covalent linked β-unit is thus recruited on the surface of the pathogen. Activation into the dimer occurs by intermolecular interaction of two Factor G sliding along the same chain of glucan. Such activation is impossible with short glucans that are not long enough to stabilize the complex and to favor the encounter of the Factor G.

5. Recruitment of Glucanases

Glycoside hydrolases play a considerable role in the digestion and recycling of fixed carbon found in polysaccharides (plant cellulose and xylan, algae laminarin, etc.). They are generally constituted of a catalytic domain linked to one or more binding domain named Carbohydrate Binding Module (CBM) [108]. Such modules lack catalytic activity but have strong affinity for the target polysaccharide. It allows increasing the concentration of enzyme at the proximity of the glycan and thus positively influencing the rate of their hydrolysis [109,110]. So far, 71 families of CBM have been described based on their amino-acids sequence, binding specificity and ternary structure [111]. They can be further categorized according to the topology of the carbohydrate-binding site [112]. According to CAZY database, β-(1→3)-glucanases could be associated with five different families of CBM (Table 1). Only five modules were successfully crystallized and their structure resolved with or without ligand.
Table 1. Isolated CBM associated with β-(1→3)-glucanases. Data available from CAZY database (www.cazy.org) in April 2015 (a X-ray data available).
Table 1. Isolated CBM associated with β-(1→3)-glucanases. Data available from CAZY database (www.cazy.org) in April 2015 (a X-ray data available).
CBM FamilyCatalytic Activity of the Associated GlucanaseOrganisms
CBM 4Endo- β-(1→3)-glucanasesPaenibacillus sp.
(E. C. 3.2.1.39/3.2.1.6)
Lichenase A/LaminarinaseRuminiclostridium thermocellum a
(E.C. 3.2.1.6/3.2.1.73)Thermotoga maritime a
Endo- β-(1→3)-glucanaseThermotoga neapolitana
(E. C. 3.2.1.39)Thermotoga petrophila
CBM 6 Bacillus halodurans a
Endo- β-(1→3)-glucanaseLysobacter enzymogenes
(E. C. 3.2.1.39)Streptomyces sioyaensis
Zobellia galactanivorans a
CBM 43 Aspergillus fumigatus
β-(1→3)-GlucanosyltransglycosylaseCandida albicans
(E.C. 2.4.1.-)Pichia pastoris
Paracoccidioides brasiliensis
Saccharomyces cerevisiae a
Schizosaccharomyces pombe
Olea europaea a
Endo-β-(1→3)-glucanasePisum sativum
(E.C. 3.2.1.39)Salix gilgiana
Triticum aestivum
CBM 52Endo-β-(1→3)-glucanase
(E.C. 3.2.1.39)		Schizosaccharomyces pombe
CBM 56Endo-β-(1→3)-glucanase
(E.C. 3.2.1.39)		Bacillus circulans
Bacillus halodurans
Paenibacillus sp.
CBM family 4 includes proteins with various substrate specificities [xylan, β-(1→4), β-(1→3), β-(1→6) and mixed β-(1→4)-β-(1→3) glucans] [113,114,115]. They are described as lectin like β-jelly roll with shallow cleft on the concave face. Recently, their specificity was studied and it is believed that it arises from the conformation of the cleft. For example, family 4 CBM from Thermotoga maritima (TmCBM4) was co-crystallized with laminariheptaose and its three-dimensional structure resolved by molecular replacement with Cellulomonas fimi CBM (CfCBM4), a β-(1→4)-glucan receptor (Figure 2) [116]. As CfCBM4, TmCBM4 shows a β-jelly roll structure but differs from the first protein in the geometry of the groove that accommodates the polysaccharide. Indeed, CfCBM4 presents a well-defined linear groove that runs through the protein. Linear β-(1→4)-glucan substrates is sandwiched within an aromatic “cradle” made of three tyrosines and the interaction is further reinforced by a weak network of H-bond with polar amino-acids. A similar organization was identified for the complex laminariheptaose-TmCBM4. The polysaccharide again is trapped between aromatic residues and the aggregate is stabilized by weak H-bond with polar loops found on the sided cliff. Here, the site of interaction adopts a “U-shaped” conformation that perfectly fits the natural conformation of the oligolaminarin. Interestingly, an additional loop, not found in CfCBM4, prevents any linear polysaccharide like β-(1→4)-glucan to fit thus explaining the specificity of the receptors. Therefore, the combination of the unique topology of the groove and the additional loops allow proteins within the same family of CBM to be specific for a particular substrate.
Figure 2. Solvent accessible surface of family 4 CBM from Thermotoga maritima complexed with laminarihexaose (a) and family 6 CBM from Bacillus halodurans complexed with laminarihexaose (b) (data from Protein Data Bank entry 1GUI and 1W9W respectively).
Figure 2. Solvent accessible surface of family 4 CBM from Thermotoga maritima complexed with laminarihexaose (a) and family 6 CBM from Bacillus halodurans complexed with laminarihexaose (b) (data from Protein Data Bank entry 1GUI and 1W9W respectively).
Different conclusions are found with CBM from 6 family specific to β-(1→3)-glucans. In this case, the selectivity for β-(1→3)-glucans is assured thanks to multiple sites of binding, one on the concave face, the other between loops at the edge of the protein. To date, the structure of two family 6 CBM were successfully resolved. The first one is associated with an endo-β-(1→3)-glucanases from B. halodurans (BhCBM6, Figure 2) [117]. BhCBM6 binds oligolaminarin with affinity that increases with the length of the substrate. ITC experiment indicates a 1 to 1 ratio between the protein and the sugar and one chain of laminarin probably binds with both sites at the surface of the protein. X-Ray data of the co-crystallized complex laminarihexaose-BhCBM6 was resolved. In contrast to TmCBM4, the oligosaccharide first interacts within a small cleft bounded by a glutamine. This cleft can accommodate only one glucose unit, the non-reducing end that is sandwiched between two tryptophan residues. From there, the oligomer curled around the protein and again adopted a natural “U shape.” At least six binding sub-sites are identified along the trail routed for the sugar and stabilize the whole by direct or water mediated H-bond. Three cations (certainly sodium) reinforce the interaction. As β-(1→4)-glucans adopted in solution a linear conformation, it could not curl like β-(1→3)-glucans but instead it will stick out of the cleft and extend into the solvent. This explains the very low affinity of BhCBM6 for xylans or mixed glucans. The same type of interaction was described for family 6 CBM from Cellvibrio mixtus, a saprophytic mesophile soil bacteria [118]. The authors confirmed the stacking of the non-reducing end with hydrophobic residues on one sub-site. The other sub-site was also identified with glutamine as essential residue that contributes mainly through H-bond interaction. Interestingly, this CBM is associated with a cellulase and not a laminarase. Fungi are the main competitors of the C. mixtus bacteria for digestion of biomass. BhCBM6 associated with the cellulase might be used to rapidly recruit the glucanase at a site of fungal invasion and thus profit of the lesion to digest easily accessible mixed-glucans or callose. Multiple bindings were also described for family 13 CBM from Cellulosimicrobium cellulans where three asparagines and one tryptophan were identified as crucial residues for the interaction [119]. The authors reported cooperative multivalent bindings of laminarin to three different repeat domains on the protein. It allows binding tightly to insoluble long glucans but moderately to shorter oligomers, main products of the glucanases thus avoiding competition. To finish, a CBM from family 43 that bind to β-(1→3)-glucans was recently found associated with a glucan transglycosylase [120]. It shows low similarity with the one found in plants [121]. The binding domain appears to tightly bind to the catalytic domain of the enzyme. The opposite face is thought to be the face of interaction with the glucan.

6. Conclusions

This review emphasizes how complex is the elucidation of fine interactions between β-(1→3)-glucans and some known receptors. This is mainly due to the wide variety of glucan structures with really more or less fine structural modulations: chain length, degree and nature of branching, nature of the enchainment of the glucosyl chain (1→3, 1→4, 1→6). This could also be linked with the variety of receptors themselves. This made numerous opportunities to bind, internalize and activate the immune system in order to not only fight opportunistic and pathogenic invasions but also to mimic such an attack by using natural or synthetic glucans as well as synthetic analogues. The latter approach offers a high potential to develop alternative therapeutics. Unfortunately, this review cannot fully focus on the mode of action of small oligo-β-(1→3)-glucans that are however potent immunostimulating agents. It can be hypothesized that analytical methods used to measure interactions with natural receptors are still not sensitive enough, or that other modes of activation of the immune system are indeed involved. As a result, further information may be obtained thanks to the development of new chemical tools, amongst them small glucans and mimetics since they can be synthetically prepared with high degree of purity and high repeatability, criteria difficult to ensure for extracted polysaccharides. Finally, this review also underlined that few crystalline data, generally of high interest to design more efficient drugs, are still required to explain how β-(1→3)-glucans bind mammalian receptors.

Acknowledgments

F.P. and C.B. thank the Région Bretagne and Goëmar (Saint Malo), and IDEALG, respectively, for supporting fellowships. The authors also thank Canceropole Grand Ouest for financial supports.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Clark, A.E.; Kerrigan, A.M.; Brown, G.D. β-Glucan receptors. In Biology and Chemistry of β-Glucans—Mechanisms of Action; Vetvicka, V., Novak, M., Eds.; Bentham Science Publishers: Oak Park, IL, USA, 2011; Volume 1, pp. 39–48. [Google Scholar]
  2. Yan, J.; Allendorf, D.J.; Brandley, B. Yeast whole glucan particle (WGP) β-glucan in conjunction with antitumor monoclonal antibodies to treat cancer. Expert Opin. Biol. Ther. 2005, 5, 691–702. [Google Scholar] [CrossRef] [PubMed]
  3. Vetvicka, V.; Sima, P. β-Glucan in invertebrates. Invertebr. Surviv. J. 2004, 1, 60–65. [Google Scholar]
  4. Chuah, C.T.; Sarko, A.; Deslandes, Y.; Marchessault, R.H. Packing analysis of carbohydrates and polysaccharides. Part 14. Triple-helical crystalline structure of curdlan and paramylon hydrates. Macromolecules 1983, 16, 1375–1382. [Google Scholar] [CrossRef]
  5. Yoshioka, Y.; Uehara, N.; Saito, H. Conformation-Dependent Change in Antitumor Activity of Linear and Branched (1,3)-β-d-Glucans on the Basis of Conformational Elucidation by Carbon-13 Nuclear Magnetic Resonance Spectroscopy. Chem. Pharm. Bull. 1992, 40, 1221–1226. [Google Scholar] [CrossRef] [PubMed]
  6. Kulicke, W.M.; Lettau, A.I.; Thielking, H. Correlation between immunological activity, molar mass, and molecular structure of different (1,3)-β-d-glucans. Carbohydr. Res. 1997, 297, 135–143. [Google Scholar] [CrossRef]
  7. Young, S.H.; Dong, W.J.; Jacobs, R.R. Observation of a partially opened triple-helix conformation in (1,3)-β-glucan by fluorescence resonance energy transfer spectroscopy. J. Biol. Chem. 2000, 275, 11874–11879. [Google Scholar] [CrossRef] [PubMed]
  8. Okobira, T.; Miyoshi, K.; Uezu, K.; Sakurai, K.; Shinkai, S. Molecular Dynamics Studies of Side Chain Effect on the β-1,3-d-Glucan Triple Helix in Aqueous Solution. Biomacromolecules 2008, 9, 783–788. [Google Scholar] [CrossRef] [PubMed]
  9. Xie, J.; Guo, L.; Ruan, Y.; Zhu, H.; Wang, L.; Zhou, L.; Yun, X.; Gu, J. Laminarin-mediated targeting to Dectin-1 enhances antigen-specific immune responses. Biochem. Biophys. Res. Commun. 2010, 391, 958–962. [Google Scholar] [CrossRef] [PubMed]
  10. Tamaru, S.; Tokunaga, D.; Hori, K.; Matsuda, S.; Shinkai, S. Giant amino acids designed on the polysaccharide scaffold and their protein-like structural interconversion. Org. Biomol. Chem. 2014, 12, 815–822. [Google Scholar] [CrossRef] [PubMed]
  11. Zhang, X.; Zhang, L.; Xu, X. Morphologies and conformation transition of lentinan in aqueous NaOH solution. Biopolymers 2004, 75, 187–195. [Google Scholar] [CrossRef] [PubMed]
  12. Sletmoen, M.; Christensen, B.E.; Stokke, B.T. Probing macromolecular architectures of nanosized cyclic structures of (1,3)-β-d-glucans by AFM and SEC-MALLS. Carbohydr. Res. 2005, 340, 971–979. [Google Scholar] [CrossRef] [PubMed]
  13. Dunstan, D.E.; Goodall, D.G. Terraced self assembled nano-structures from laminarin. Int. J. Biol. Macromol. 2007, 40, 362–366. [Google Scholar] [CrossRef] [PubMed]
  14. Adachi, Y.; Ishii, T.; Ikeda, Y.; Hoshino, A.; Tamura, H.; Aketagawa, J.; Tanaka, S.; Ohno, N. Characterization of β-glucan recognition site on C-type lectin, dectin 1. Infect. Immun. 2004, 72, 4159–4171. [Google Scholar] [CrossRef] [PubMed]
  15. Harada, T. Production, properties, and application of curdlan. In Extracellular Microbial Polysaccharides; Sandford, P.A., Laskin, A., Eds.; Am. Chem. Soc. Publishers: Washington, DC, USA, 1977; Volume 45, pp. 265–283. [Google Scholar]
  16. Ogawa, K.; Tsurugi, J.; Watanabe, T. The dependence of the conformation of a (1,3)-β-d-glucan on chain-length in alkaline solution. Carbohydr. Res. 1973, 29, 397–403. [Google Scholar] [CrossRef]
  17. Buck, K.W.; Chen, A.W.; Dickerson, A.G.; Chain, E.B. Formation and Structure of Extracellular Glucans Produced by Claviceps Species. J. Gen. Macrobiol. 1968, 51, 337–352. [Google Scholar] [CrossRef]
  18. Perlin, A.S.; Taber, W.A. A glucan produced by Claviceps purpurea. Can. J. Chem. 1963, 41, 2278–2282. [Google Scholar] [CrossRef]
  19. Brown, G.D.; Gordon, S. Immune recongnition. A new receptor for β-glucans. Nature 2001, 413, 36–37. [Google Scholar] [CrossRef] [PubMed]
  20. Batbayar, S.; Lee, D.H.; Kim, H.W. Immunomodulation of fungal β-Glucan in host defense signaling by Dectin-1. Biomol. Ther. 2012, 20, 433–445. [Google Scholar] [CrossRef] [PubMed]
  21. Gantner, B.N.; Simmons, R.M.; Canavera, S.J.; Akira, S.; Underhill, D.M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 2003, 197, 1107–1117. [Google Scholar] [CrossRef] [PubMed]
  22. Brown, G.D. Dectin-1: A signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol. 2006, 6, 33–43. [Google Scholar] [CrossRef] [PubMed]
  23. Baldwin, K.T.; Carbajal, K.S.; Segal, B.M.; Gigera, R.J. Neuroinflammation triggered by β-glucan/dectin-1 signaling enables CNS axon regeneration. PNAS 2015, 112, 2581–2586. [Google Scholar] [CrossRef] [PubMed]
  24. Mansour, M.K.; Tam, J.M.; Khan, N.S.; Seward, M.; Davids, P.J.; Puranam, S.; Sokolovska, A.; Sykes, D.B.; Dagher, Z.; Becker, C.; et al. Dectin-1 Activation Controls Maturation of β-1,3-Glucan-containing Phagosomes. J. Biol. Chem. 2013, 288, 16043–16054. [Google Scholar] [CrossRef] [PubMed]
  25. Fang, J.P.; Wang, Y.; Lv, X.F.; Shen, X.K.; Ni, X.; Ding, L. Structure of a β-glucan from Grifola frondosa and its antitumor effects by activating Dectin-1/Syk/NF-κB signaling. Glycoconj. J. 2010, 29, 365–377. [Google Scholar] [CrossRef] [PubMed]
  26. Willcocks, S.; Offord, V.; Seyfert, H.M.; Coffey, T.J.; Werling, D. Species-specific PAMP recognition by TLR2 and evidence for species-restricted interaction with Dectin-1. J. Leukoc. Biol. 2013, 94, 449–458. [Google Scholar] [CrossRef] [PubMed]
  27. Chan, G.; Chan, W.; Sze, D. The effects of β-glucan on human immune and cancer cells. J. Hematol. Oncol. 2009, 2. [Google Scholar] [CrossRef] [PubMed]
  28. Adachi, Y. Role of the 1,3-β-d-glucan receptor dectin-1 in fungal infection and activation of innate and anti-tumor immunity. Trends Glycosci. Glycotechnol. 2007, 19, 195–207. [Google Scholar] [CrossRef]
  29. Veldhuizen, E.J.A.; van Eijk, M.; Haagsman, H.P. The carbohydrate recognition domain of collectins. FEBS J. 2011, 278, 3930–3941. [Google Scholar] [CrossRef] [PubMed]
  30. Palma, A.S.; Feizi, T.; Zhang, Y.; Stoll, M.S.; Lawson, A.M.; Dıaz-Rodrıguez, E.; Campanero-Rhodes, M.A.; Costa, J.; Gordon, S.; Brown, G.D.; et al. Ligands for the β-Glucan Receptor, Dectin-1, Assigned Using “Designer” Microarrays of Oligosaccharide Probes (Neoglycolipids) Generated from Glucan Polysaccharides. J. Biol. Chem. 2006, 281, 5771–5779. [Google Scholar] [CrossRef] [PubMed]
  31. Sylla, B.; Guegan, J.P.; Wieruszeski, J.M.; Nugier-Chauvin, C.; Legentil, L.; Daniellou, R.; Ferrieres, V. Probing β-(1→3)-d-glucans interactions with recombinant human receptors using high-resolution NMR studies. Carbohydr. Res. 2011, 346, 1490–1494. [Google Scholar] [CrossRef] [PubMed]
  32. Hanashima, S.; Ikeda, A.; Tanaka, H.; Adachi, Y.; Ohno, N.; Takahashi, T.; Yamaguchi, Y. NMR study of short β(1–3)-glucans provides insights into the structure and interaction with Dectin-1. Glycoconj. J. 2014, 31, 199–207. [Google Scholar] [CrossRef] [PubMed]
  33. Liao, G.; Zhou, Z.; Burgula, S.; Liao, J.; Yuan, C.; Wu, Q.; Guo, Z. Synthesis and Immunological Studies of Linear Oligosaccharides of β-Glucan As Antigens for Antifungal Vaccine Development. Bioconj. Chem. 2015, 26, 466–476. [Google Scholar] [CrossRef] [PubMed]
  34. Donadei, A.; Gallorini, S.; Berti, F.; O’Hagan, D.T.; Adamo, R.; Baudner, B.C. Rational Design of Adjuvant for Skin Delivery: Conjugation of Synthetic β-Glucan Dectin-1 Agonist to Protein Antigen. Mol. Pharm. 2015, 12, 1662–1672. [Google Scholar] [CrossRef] [PubMed]
  35. Adams, E.L.; Rice, P.J.; Graves, B.; Ensley, H.E.; Yu, H.; Brown, G.D.; Gordon, S.; Monteiro, M.A.; Papp-Szabo, E.; Lowman, D.W.; et al. Differential High-Affinity Interaction of Dectin-1 with Natural or Synthetic Glucans Is Dependent upon Primary Structure and Is Influenced by Polymer Chain Length and Side-Chain Branching. J. Pharmacol. Exp. Ther. 2008, 325, 115–123. [Google Scholar] [CrossRef] [PubMed]
  36. Tada, R.; Adachi, Y.; Ishibashi, K.I.; Tsukbaki, K.; Ohno, N. Binding Capacity of a Barley β-d-Glucan to the β-Glucan Recognition Molecule Dectin-1. J. Agric. Food Chem. 2008, 56, 1442–1450. [Google Scholar] [CrossRef] [PubMed]
  37. Chaung, H.C.; Huang, T.C.; Yu, J.H.; Wu, M.L.; Chung, W.B. Immunomodulatory effects of β-glucans on porcine alveolar macrophages and bone marrow haematopoietic cell-derived dendritic cells. Vet. Immunol. Immunopathol. 2009, 131, 147–157. [Google Scholar] [CrossRef] [PubMed]
  38. Stambach, N.S.; Taylor, M.E. Characterization of carbohydrate recognition by Langerin, a C-type lectin of Langerhans cells. Glycobiology 2003, 13, 401–410. [Google Scholar] [CrossRef] [PubMed]
  39. De Jong, M.A.W.P.; Vriend, L.E.M.; Theelen, B.; Taylor, M.E.; Fluitsma, D.; Boekhout, T.; Geijtenbeek, T.B.H. C-type lectin Langerin is a β-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi. Mol. Immunol. 2010, 47, 1216–1225. [Google Scholar] [CrossRef] [PubMed]
  40. Feinberg, H.; Taylor, M.E.; Razi, N.; McBride, R.; Knirel, Y.A.; Graham, S.A.; Drickamer, K.; Weis, W.I. Structural Basis for Langerin Recognition of Diverse Pathogen and Mammalian Glycans through a Single Binding Site. J. Mol. Biol. 2011, 405, 1027–1039. [Google Scholar] [CrossRef] [PubMed]
  41. De Jesus, M.; Ostroff, G.R.; Levitz, S.M.; Bartling, T.R.; Mantis, N.J. A population of langerin-positive dendritic cells in murine Peyer’s patches involved in sampling β-glucan microparticles. PLoS ONE 2014, 9, e91002. [Google Scholar] [CrossRef] [PubMed]
  42. Ross, G.D.; Vetvicka, V.; Yan, J.; Xia, Y.; Vetvickova, J. Therapeutic intervention with complement and β-glucan in cancer. Immunopharmacol. 1999, 42, 61–74. [Google Scholar] [CrossRef]
  43. Xia, Y.; Borland, G.; Huang, J.; Mizukami, I.F.; Petty, H.R.; Todd, R.F.; Ross, G.D. Function of the Lectin Domain of Mac-1/Complement Receptor Type 3 (CD11b/CD18) in Regulating Neutrophil Adhesion. J. Immunol. 2002, 169, 6417–6426. [Google Scholar] [CrossRef] [PubMed]
  44. Tsikitis, V.L.; Morin, N.A.; Harrington, E.O.; Albina, J.E.; Reichner, J.S. The Lectin-Like Domain of Complement Receptor 3 Protects Endothelial Barrier Function from Activated Neutrophils. J. Immunol. 2004, 173, 1284–1291. [Google Scholar] [CrossRef] [PubMed]
  45. Harler, M.B.; Wakshull, E.; Filardo, E.J.; Albina, J.E.; Reichner, J.S. Promotion of Neutrophil Chemotaxis Through Differential Regulation of β1 and β2 Integrins. J. Immunol. 1999, 162, 6792–6799. [Google Scholar] [PubMed]
  46. Van Bruggen, R.; Drewniak, A.; Jansen, M.; van Houdt, M.; Roos, D.; Chapel, H.; Verhoeven, A.J.; Kuijpers, T.W. Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for β-glucan-bearing particles. Mol. Immunol. 2009, 47, 575–581. [Google Scholar] [CrossRef] [PubMed]
  47. O’Brien, X.M.; Heflin, K.E.; Lavigne, L.M.; Yu, K.; Kim, M.; Salomon, A.R.; Reichner, J.S. Lectin Site Ligation of CR3 Induces Conformational Changes and Signaling. J. Biol. Chem. 2012, 287, 3337–3348. [Google Scholar] [CrossRef] [PubMed]
  48. Xia, Y.; Vetvicka, V.; Yun, J.; Hanikyrova, M.; Mayadas, T.; Ross, G.D. The β-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J. Immunol. 1999, 162, 2281–2290. [Google Scholar] [PubMed]
  49. Hong, F.; Yan, J.; Baran, J.T.; Allendorf, D.J.; Hansen, R.D.; Ostroff, G.R.; Xing, P.X.; Cheung, N.K.V.; Ross, G.D. Mechanism by Which Orally Administered β-1,3-Glucans Enhance the Tumoricidal Activity of Antitumor Monoclonal Antibodies in Murine Tumor Models. J. Immunol. 2004, 173, 797–806. [Google Scholar] [CrossRef] [PubMed]
  50. Thornton, B.P.; Vĕtvicka, V.; Pitman, M.; Goldman, R.C.; Ross, G.D. Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 1996, 156, 1235–1246. [Google Scholar] [PubMed]
  51. Bose, N.; Chan, A.S.H.; Guerrero, F.; Maristany, C.M.; Walsh, R.M.; Ertelt, K.E.; Jonas, A.B.; Gorden, K.B.; Dudney, C.M.; Wurst, L.R.; et al. Binding of soluble yeast β-glucan to human neutrophils and monocytes is complement-dependent. Front. Immunol. 2013, 4, 230. [Google Scholar] [CrossRef] [PubMed]
  52. Ferry, A.; Malik, G.; Guinchard, X.; Vetvicka, V.; Crich, D. Synthesis and Evaluation of Di- and Trimeric Hydroxylamine-Based β-(1→3)-Glucan Mimetics. J. Am. Chem. Soc. 2014, 136, 14852–14857. [Google Scholar] [CrossRef] [PubMed]
  53. Jamois, F.; Ferrières, V.; Guégan, J.P.; Yvin, J.C.; Plusquellec, D.; Vetvicka, V. Glucan-like synthetic oligosaccharides: Iterative synthesis of linear oligo-β-(1,3)-glucans and immunostimulatory effects. Glycobiology 2005, 15, 393–407. [Google Scholar] [CrossRef] [PubMed]
  54. Saraswat-Ohri, S.; Vashishta, A.; Vetvicka, V.; Descroix, K.; Jamois, F.; Yvin, J.C.; Ferrières, V. Biological properties of (1→3)-beta-d-glucan-based synthetic oligosaccharides. J. Med. Food 2011, 14, 369–376. [Google Scholar] [CrossRef] [PubMed]
  55. Vetvicka, V.; Saraswat-Ohri, S.; Vashishta, A.; Descroix, K.; Jamois, F.; Yvin, J.C.; Ferrières, V. New 4-deoxy-(1→3)-β-d-glucan-based oligosaccharides and their immunostimulating potential. Carbohydr. Res. 2011, 346, 2213–2221. [Google Scholar] [CrossRef] [PubMed]
  56. Descroix, K.; Větvička, V.; Laurent, I.; Jamois, F.; Yvin, J.-C.; Ferrières, V. New oligo-beta-(1,3)-glucan derivatives as immunostimulating agents. Bioorganic Med. Chem. 2010, 18, 348–357. [Google Scholar] [CrossRef] [PubMed]
  57. Sylla, B.; Legentil, L.; Saraswat-Ohri, S.; Vashishta, A.; Daniellou, R.; Wang, H.W.; Vetvicka, V.; Ferrières, V. Oligo-β-(1→3)-glucans: Impact of thio-bridges on immunostimulating activities and the development of cancer stem cells. J. Med. Chem. 2014, 57, 8280–8292. [Google Scholar] [CrossRef] [PubMed]
  58. Zimmerman, J.W.; Lindermuth, J.; Fish, P.A.; Palace, G.P.; Stevenson, T.T.; DeMong, D.E. A novel carbohydrate-glycosphingolipid interaction between a β-(1–3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J. Biol. Chem. 1998, 273, 22014–22020. [Google Scholar] [CrossRef] [PubMed]
  59. Tsikitis, V.L.; Martin, A.; Albina, J.; Reichner, J. Ligation of the lactosylceramide receptor (CDw17) promotes neutrophil migration. J. Am. Coll. Surg. 2004, 199, 44. [Google Scholar] [CrossRef]
  60. Wakshull, E.; Brunke-Reese, D.; Lindermuth, J.; Fisette, L.; Nathans, R.S.; Crowley, J.J.; Tufts, J.C.; Zimmerman, J.; Mackin, W.; Adams, D.S. PGG-Glucan, a soluble β-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-κB-like factor in human PMN: Evidence for a glycosphingolipid β-(1,3)-glucan receptor. Immunopharmacology 1999, 41, 89–107. [Google Scholar] [CrossRef]
  61. Hahn, P.Y.; Evans, S.E.; Kottom, T.J.; Standing, J.E.; Pagano, R.E.; Limper, A.H. Pneumocystis carinii cell wall β-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide-mediated mechanism. J. Biol. Chem. 2003, 278, 2043–2050. [Google Scholar] [CrossRef] [PubMed]
  62. Akramiene, D.; Kondrotas, A.; Didziapetriene, J.; Kevelaitis, E. Effects of β-glucans on the immune system. Medicina (Kaunas) 2007, 43, 597–606. [Google Scholar] [PubMed]
  63. Dzik, J.M. The ancestry and cumulative evolution of immune reactions. Acta Biochim. Pol. 2010, 57, 443–466. [Google Scholar] [PubMed]
  64. Rice, P.J.; Kelley, J.L.; Kogan, G.; Ensley, H.E.; Kalbfleisch, J.H.; Browder, I.W.; Williams, D.L. Human monocyte scavenger receptors are pattern recognition receptors for (1→3)-β-d-glucans. J. Leukoc. Biol. 2002, 72, 140–146. [Google Scholar] [PubMed]
  65. Vera, J.; Fenutria, R.; Canadas, O.; Figueras, M.; Mota, R.; Sarrias, M.R.; Williams, D.L.; Casals, C.; Yelamos, J.; Lozano, F. The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome. Proc. Natl. Acad. Sci. USA 2009, 106, 1506–1511. [Google Scholar] [CrossRef] [PubMed]
  66. Van de Veerdonk, F.L.; Joosten, L.A.B.; Devesa, I.; Mora-Montes, H.M.; Kanneganti, T.D.; Dinarello, C.A.; van der Meer, J.W.M.; Gow, N.A.R.; Kullberg, B.J.; Netea, M.G. Bypassing Pathogen-Induced Inflammasome Activation for the Regulation of Interleukin-1β Production by the Fungal Pathogen Candida albicans. J. Infect. Dis. 2009, 199, 1087–1096. [Google Scholar] [CrossRef] [PubMed]
  67. Kankkunen, P.; Teirilä, L.; Rintahaka, J.; Alenius, H.; Wolff, H.; Matikainen, S. (1,3)-β-Glucans Activate Both Dectin-1 and NLRP3 Inflammasome in Human Macrophages. J. Immunol. 2010, 184, 6335–6342. [Google Scholar] [CrossRef] [PubMed]
  68. Matsushita, M.; Fujita, T. Ficolins and the lectin complement pathway. Immunol. Rev. 2001, 180, 78–85. [Google Scholar] [CrossRef] [PubMed]
  69. Lynch, N.J.; Roscher, S.; Hartung, T.; Morath, S.; Matsushita, M.; Maennel, D.N.; Kuraya, M.; Fujita, T.; Schwaeble, W.J. L-Ficolin Specifically Binds to Lipoteichoic Acid, a Cell Wall Constituent of Gram-Positive Bacteria, and Activates the Lectin Pathway of Complement. J. Immunol. 2004, 172, 1198–1202. [Google Scholar] [CrossRef] [PubMed]
  70. Krarup, A.; Sørensen, U.B.S.; Matsushita, M.; Jensenius, J.C.; Thiel, S. Effect of Capsulation of Opportunistic Pathogenic Bacteria on Binding of the Pattern Recognition Molecules Mannan-Binding Lectin, L-Ficolin, and H-Ficolin. Infect. Immun. 2005, 73, 1052–1060. [Google Scholar] [CrossRef] [PubMed]
  71. Ma, Y.G.; Cho, M.Y.; Zhao, M.; Park, J.W.; Matsushita, M.; Fujita, T.; Lee, B.L. Human Mannose-binding Lectin and l-Ficolin Function as Specific Pattern Recognition Proteins in the Lectin Activation Pathway of Complement. J. Biol. Chem. 2004, 279, 25307–25312. [Google Scholar] [CrossRef] [PubMed]
  72. Garlatti, V.; Belloy, N.; Martin, L.; Lacroix, M.; Matsushita, M.; Endo, Y.; Fujita, T.; Fontecilla-Camps, J.C.; Arlaud, G.J.; Thielens, N.M.; et al. Structural insights into the innate immune recognition specificities of L- and H-ficolins. EMBO J. 2007, 26, 623–633. [Google Scholar] [CrossRef] [PubMed]
  73. Roh, K.B.; Kim, C.H.; Lee, H.; Kwon, H.M.; Park, J.W.; Ryu, J.H.; Kurokawa, K.; Ha, N.C.; Lee, W.J.; Lemaitre, B.; et al. Proteolytic Cascade for the Activation of the Insect Toll Pathway Induced by the Fungal Cell Wall Component. J. Biol. Chem. 2009, 284, 19474–19481. [Google Scholar] [CrossRef] [PubMed]
  74. Lee, M.H.; Osaki, T.; Lee, J.Y.; Baek, M.J.; Zhang, R.; Park, J.W.; Kawabata, S.; Söderhäll, K.; Lee, B.L. Peptidoglycan Recognition Proteins Involved in 1,3-β-d-Glucan-dependent Prophenoloxidase Activation System of Insect. J. Biol. Chem. 2004, 279, 3218–3227. [Google Scholar] [CrossRef] [PubMed]
  75. Sukhithasri, V.; Nisha, N.; Biswas, L.; Anil Kumar, V.; Biswas, R. Innate immune recognition of microbial cell wall components and microbial strategies to evade such recognitions. Microbiol. Res. 2013, 168, 396–406. [Google Scholar] [CrossRef] [PubMed]
  76. Brown, G.D.; Gordon, S. Immune recognition of fungal β-glucans. Cell. Microbiol. 2005, 7, 471–479. [Google Scholar] [CrossRef] [PubMed]
  77. Rao, X.J.; Zhong, X.; Lin, X.Y.; Huang, X.H.; Yu, X.Q. Characterization of a novel Manduca sexta beta-1, 3-glucan recognition protein (βGRP3) with multiple functions. Insect Biochem. Mol. Biol. 2014, 52, 13–22. [Google Scholar] [CrossRef] [PubMed]
  78. Shi, X.Z.; Yu, X.Q. The extended loop of the C-terminal carbohydrate-recognition domain of Manduca sexta immulectin-2 is important for ligand binding and functions. Amino Acids 2012, 42, 2383–2391. [Google Scholar] [CrossRef] [PubMed]
  79. Wang, Y.; Jiang, H. Binding properties of the regulatory domains in Manduca sexta hemolymph proteinase-14, an initiation enzyme of the prophenoloxidase activation system. Dev. Comp. Immunol. 2010, 34, 316–322. [Google Scholar] [CrossRef] [PubMed]
  80. Hughes, A. Evolution of the βGRP/GNBP/β-1,3-glucanase family of insects. Immunogenetics 2012, 64, 549–558. [Google Scholar] [CrossRef] [PubMed]
  81. Ochiai, M.; Ashida, M. A Pattern-recognition Protein for β-1,3-Glucan: The binding domain and the cDNA cloning of the β-1,3-glucan recognition protein from the skillworm, Bombyx mori. J. Biol. Chem. 2000, 275, 4995–5002. [Google Scholar] [CrossRef] [PubMed]
  82. Ma, C.; Kanost, M.R. A β1,3-Glucan Recognition Protein from an Insect, Manduca sexta, Agglutinates Microorganisms and Activates the Phenoloxidase Cascade. J. Biol. Chem. 2000, 275, 7505–7514. [Google Scholar] [CrossRef] [PubMed]
  83. Fabrick, J.A.; Baker, J.E.; Kanost, M.R. Innate Immunity in a Pyralid Moth: Functional of domains from a β-1,3-glucan recognition protein. J. Biol. Chem. 2004, 279, 26605–26611. [Google Scholar] [CrossRef] [PubMed]
  84. Takahashi, D.; Dai, H.; Hiromasa, Y.; Krishnamoorthi, R.; Kanost, M.R. Self-association of an insect β-1,3-glucan recognition protein upon binding laminarin stimulates prophenoloxidase activation as an innate immune response. J. Biol. Chem. 2014, 289, 28399–28410. [Google Scholar] [CrossRef] [PubMed]
  85. Dai, H.; Hiromasa, Y.; Takahashi, D.; VanderVelde, D.; Fabrick, J.A.; Kanost, M.R.; Krishnamoorthi, R. An Initial Event in the Insect Innate Immune Response: Structural and Biological Studies of Interactions between β-1,3-Glucan and the N-Terminal Domain of β-1,3-Glucan Recognition Protein. Biochemistry 2013, 52, 161–170. [Google Scholar] [CrossRef] [PubMed]
  86. Kanagawa, M.; Satoh, T.; Ikeda, A.; Adachi, Y.; Ohno, N.; Yamaguchi, Y. Structural Insights into Recognition of Triple-helical β-Glucans by an Insect Fungal Receptor. J. Biol. Chem. 2011, 286, 29158–29165. [Google Scholar] [CrossRef] [PubMed]
  87. Takahasi, K.; Ochiai, M.; Horiuchi, M.; Kumeta, H.; Ogura, K.; Ashida, M.; Inagaki, F. Solution structure of the silkworm βGRP/GNBP3 N-terminal domain reveals the mechanism for β-1,3-glucan-specific recognition. PNAS 2009, 106, 11679–11684. [Google Scholar] [CrossRef] [PubMed]
  88. Mishima, Y.; Quintin, J.; Aimanianda, V.; Kellenberger, C.; Coste, F.; Clavaud, C.; Hetru, C.; Hoffmann, J.A.; Latgé, J.P.; Ferrandon, D.; et al. The N-terminal Domain of Drosophila Gram-negative Binding Protein 3 (GNBP3) Defines a Novel Family of Fungal Pattern Recognition Receptors. J. Biol. Chem. 2009, 284, 28687–28697. [Google Scholar] [CrossRef] [PubMed]
  89. Chamy, L.E.; Leclerc, V.; Caldelari, I.; Reichhart, J.M. Sensing of ‘danger signals’ and pathogen-associated molecular patterns defines binary signaling pathways ‘upstream’ of Toll. Nat. Immunol. 2008, 9, 1165–1170. [Google Scholar] [CrossRef] [PubMed]
  90. Weis, W.I.; Drickamer, K. Structural Basis of Lectin-Carbohydrate Recognition. Ann. Rev. Biochem. 1996, 65, 441–473. [Google Scholar] [CrossRef] [PubMed]
  91. Rini, J.M. Lectin Structure. Ann. Rev. Biophys. Biomol. Struct. 1995, 24, 551–577. [Google Scholar] [CrossRef] [PubMed]
  92. Fabrick, J.A.; Baker, J.E.; Kanost, M.R. cDNA cloning, purification, properties, and function of a β-1,3-glucan recognition protein from a pyralid moth, Plodia interpunctella. Insect Biochem. Mol. Biol. 2003, 33, 579–594. [Google Scholar] [CrossRef]
  93. Tong, Y.; Kanost, M.R. Manduca sexta Serpin-4 and Serpin-5 Inhibit the Prophenol Oxidase Activation Pathway: cDNA cloning, protein expression, and characterization. J. Biol. Chem. 2005, 280, 14923–14931. [Google Scholar] [CrossRef] [PubMed]
  94. Duvic, B.; Söderhäll, K. Purification and characterization of a beta-1,3-glucan binding protein from plasma of the crayfish Pacifastacus leniusculus. J. Biol. Chem. 1990, 265, 9327–9332. [Google Scholar] [PubMed]
  95. Wang, X.-W.; Wang, J.-X. Pattern recognition receptors acting in innate immune system of shrimp against pathogen infections. Fish Shellfish Immunol. 2013, 34, 981–989. [Google Scholar] [CrossRef] [PubMed]
  96. Wang, L.; Qiu, L.; Zhou, Z.; Song, L. Research progress on the mollusc immunity in China. Dev. Comp. Immunol. 2013, 39, 2–10. [Google Scholar] [CrossRef] [PubMed]
  97. Du, X.J.; Zhao, X.F.; Wang, J.X. Molecular cloning and characterization of a lipopolysaccharide and β-1,3-glucan binding protein from fleshy prawn (Fenneropenaeus chinensis). Mol. Immunol. 2007, 44, 1085–1094. [Google Scholar] [CrossRef] [PubMed]
  98. Dziarski, R. Peptidoglycan recognition proteins (PGRPs). Mol. Immunol. 2004, 40, 877–886. [Google Scholar] [CrossRef] [PubMed]
  99. Lee, S.Y.; Söderhäll, K. Early events in crustacean innate immunity. Fish Shellfish Immunol. 2002, 12, 421–437. [Google Scholar] [PubMed]
  100. Cerenius, L.; Liang, Z.; Duvic, B.; Keyser, P.; Hellman, U.; Palva, E.T.; Iwanaga, S.; Söderhäll, K. Structure and biological activity of a 1,3-beta-d-glucan-binding protein in crustacean blood. J. Biol. Chem. 1994, 269, 29462–29467. [Google Scholar] [PubMed]
  101. Hou, L.; Liu, X.; Jing, Y.; Zhang, J.; Ding, Z.; Huang, Y.; Gu, W.; Meng, Q.; Wang, W. Molecular cloning and characterization of the lipopolysaccharide and β-1,3-glucan binding protein from red claw crayfish, Cherax quadricarinatus. Aquaculture 2015, 441, 1–7. [Google Scholar] [CrossRef]
  102. Sivakamavalli, J.; Vaseeharan, B. Bifunctional role of a pattern recognition molecule β-1,3 glucan binding protein purified from mangrove crab Episesarma tetragonum. J. Invertebr. Pathol. 2014, 119, 25–31. [Google Scholar] [CrossRef] [PubMed]
  103. Sivakamavalli, J.; Selvaraj, C.; Singh, S.K.; Vaseeharan, B. Interaction investigations of crustacean β-GBP recognition toward pathogenic microbial cell membrane and stimulate upon prophenoloxidase activation. J. Mol. Recognit. 2014, 27, 173–183. [Google Scholar] [CrossRef] [PubMed]
  104. Sivakamavalli, J.; Tripathi, S.K.; Singh, S.K.; Vaseeharan, B. Homology modeling, molecular dynamics, and docking studies of pattern-recognition transmembrane protein-lipopolysaccharide and β-1,3 glucan-binding protein from Fenneropenaeus indicus. J. Biomol. Struct. Dyn. 2015, 33, 1269–1280. [Google Scholar] [CrossRef] [PubMed]
  105. Muta, T.; Seki, N.; Takaki, Y.; Hashimoto, R.; Oda, T.; Iwanaga, A.; Tokunaga, F.; Iwanaga, S. Purified Horseshoe Crab Factor G: Recontitution and characterization of the (1,3)-β-d-glucan-sensitive serine protease cascade. J. Biol. Chem. 1995, 270, 892–897. [Google Scholar] [CrossRef] [PubMed]
  106. Seki, N.; Muta, T.; Oda, T.; Iwaki, D.; Kuma, K.; Miyata, T.; Iwanaga, S. Horseshoe crab (1,3)-beta-d-glucan-sensitive coagulation factor G. A serine protease zymogen heterodimer with similarities to beta-glucan-binding proteins. J. Biol. Chem. 1994, 269, 1370–1374. [Google Scholar] [PubMed]
  107. Takaki, Y.; Seki, N.; Kawabata, S.; Iwanaga, S.; Muta, T. Duplicated Binding Sites for (1→3)-β-d-Glucan in the Horseshoe Crab Coagulation Factor G: Implications for a molecular basis of thepattern recognition in innate immunity. J. Biol. Chem. 2002, 277, 14281–14287. [Google Scholar] [CrossRef] [PubMed]
  108. Davies, G.J.; Henrissat, B. Structural enzymology of carbohydrate-active enzymes: Implications for the post-genomic era. Biochem. Soc. Trans. 2002, 30, 291–297. [Google Scholar] [CrossRef] [PubMed]
  109. Bolam, D.N.; Ciruela, A.; Mcqueen-Mason, S.; Simpson, P.; Williamson, M.P.; Rixon, J.E.; Boraston, A.; Hazlewood, G.P.; Gilbert, H.J. Pseudomonas cellulose-binding domains mediate their effects by increasing enzyme substrate proximity. Biochem. J. 1998, 331, 775–781. [Google Scholar] [PubMed]
  110. Gill, J.; Rixon, J.E.; Bolam, D.N.; Mcqueen-Mason, S.; Simpson, P.J.; Williamson, M.P.; Hazlewood, G.P.; Gilbert, H.J. The type II and X cellulose-binding domains of Pseudomonas xylanase A potentiate catalytic activity against complex substrates by a common mechanism. Biochem. J. 1999, 342, 473–480. [Google Scholar] [CrossRef] [PubMed]
  111. Coutinho, P.M.; Henrissat, B. Recent Advances in Carbohydrate Bioengineering; Royal Society of Chemistry: Cambridge, UK, 1999. [Google Scholar]
  112. Boraston, A.B.; Bolam, D.N.; Gilbert, H.J.; Davies, G.J. Carbohydrate-binding modules: Fine tuning polysaccharide recognition. Biochem. J. 2004, 382, 769–772. [Google Scholar] [PubMed]
  113. Boraston, A.B.; Warren, R.A.J.; Kilburn, D.G. β-1,3-Glucan Binding by a Thermostable Carbohydrate-Binding Module from Thermotoga maritima. Biochemistry 2001, 40, 14679–14685. [Google Scholar] [CrossRef] [PubMed]
  114. Tomme, P.; Creagh, A.L.; Kilburn, D.G.; Haynes, C.A. Interaction of Polysaccharides with the N-Terminal Cellulose-Binding Domain of Cellulomonas fimi CenC. 1. Binding Specificity and Calorimetric Analysis. Biochemistry 1996, 35, 13885–13894. [Google Scholar] [CrossRef] [PubMed]
  115. Abou-Hachem, M.; Nordberg-Karlsson, E.; BartonekRoxa, E.; Raghothama, S.; Simpson, P.J.; Gilbert, H.J.; Williamson, M.P.; Holst, O. Carbohydrate-binding modules from a thermostable Rhodothermus marinus xylanase: Cloning, expression and binding studies. Biochem. J. 2000, 345, 53–60. [Google Scholar] [CrossRef] [PubMed]
  116. Boraston, A.B.; Nurizzo, D.; Notenboom, V.; Ducros, V.; Rose, D.R.; Kilburn, D.G.; Davies, G.J. Differential Oligosaccharide Recognition by Evolutionarily-related β-1,4 and β-1,3 Glucan-binding Modules. J. Mol. Biol. 2002, 319, 1143–1156. [Google Scholar] [CrossRef]
  117. Van Bueren, A.L.; Morland, C.; Gilbert, H.J.; Boraston, A.B. Family 6 Carbohydrate Binding Modules Recognize the Non-reducing End of β-1,3-Linked Glucans by Presenting a Unique Ligand Binding Surface. J. Biol. Chem. 2005, 280, 530–537. [Google Scholar] [CrossRef] [PubMed]
  118. Correia, M.A.S.; Pires, V.M.R.; Gilbert, H.J.; Bolam, D.N.; Fernandes, V.O.; Alves, V.D.; Prates, J.A.M.; Ferreira, L.M.A.; Fontes, C.M.G.A. Family 6 carbohydrate-binding modules display multiple β1,3-linked glucan-specific binding interfaces. FEMS Microbiol. Lett. 2009, 300, 48–57. [Google Scholar] [CrossRef] [PubMed][Green Version]
  119. Tamashiro, T.; Tanabe, Y.; Ikura, T.; Ito, N.; Oda, M. Critical roles of Asp270 and Trp273 in the α-repeat of the carbohydrate-binding module of endo-1,3-β-glucanase for laminarin-binding avidity. Glycoconj. J. 2012, 29, 77–85. [Google Scholar] [CrossRef] [PubMed]
  120. Hurtado-Guerrero, R.; Schüttelkopf, A.W.; Mouyna, I.; Ibrahim, A.F.M.; Shepherd, S.; Fontaine, T.; Latgé, J.P.; van Aalten, D.M.F. Molecular Mechanisms of Yeast Cell Wall Glucan Remodeling. J. Biol. Chem. 2009, 284, 8461–8469. [Google Scholar] [CrossRef] [PubMed]
  121. Treviño, M.Á.; Palomares, O.; Castrillo, I.; Villalba, M.; Rodríguez, R.; Rico, M.; Santoro, J.; Bruix, M. Solution structure of the C-terminal domain of Ole e 9, a major allergen of olive pollen. Prot. Sci. 2008, 17, 371–376. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Legentil, L.; Paris, F.; Ballet, C.; Trouvelot, S.; Daire, X.; Vetvicka, V.; Ferrières, V. Molecular Interactions of β-(1→3)-Glucans with Their Receptors. Molecules 2015, 20, 9745-9766. https://doi.org/10.3390/molecules20069745

AMA Style

Legentil L, Paris F, Ballet C, Trouvelot S, Daire X, Vetvicka V, Ferrières V. Molecular Interactions of β-(1→3)-Glucans with Their Receptors. Molecules. 2015; 20(6):9745-9766. https://doi.org/10.3390/molecules20069745

Chicago/Turabian Style

Legentil, Laurent, Franck Paris, Caroline Ballet, Sophie Trouvelot, Xavier Daire, Vaclav Vetvicka, and Vincent Ferrières. 2015. "Molecular Interactions of β-(1→3)-Glucans with Their Receptors" Molecules 20, no. 6: 9745-9766. https://doi.org/10.3390/molecules20069745

APA Style

Legentil, L., Paris, F., Ballet, C., Trouvelot, S., Daire, X., Vetvicka, V., & Ferrières, V. (2015). Molecular Interactions of β-(1→3)-Glucans with Their Receptors. Molecules, 20(6), 9745-9766. https://doi.org/10.3390/molecules20069745

Article Metrics

Back to TopTop